Swayampakula Ramakanth
Stock Analyst at HC Wainwright & Co.
(3.60)
# 803
Out of 5,154 analysts
477
Total ratings
40.17%
Success rate
8.85%
Average return
Main Sectors:
Stocks Rated by Swayampakula Ramakanth
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| ETON Eton Pharmaceuticals | Maintains: Buy | $35 → $37 | $16.80 | +120.24% | 9 | Mar 2, 2026 | |
| VCEL Vericel | Maintains: Buy | $60 → $64 | $33.71 | +89.85% | 19 | Feb 27, 2026 | |
| CORT Corcept Therapeutics | Maintains: Buy | $67 → $60 | $33.87 | +77.15% | 29 | Feb 25, 2026 | |
| ECOR electroCore | Maintains: Buy | $25 → $18 | $6.85 | +162.77% | 14 | Jan 26, 2026 | |
| MIRM Mirum Pharmaceuticals | Maintains: Buy | $102 → $130 | $86.30 | +50.64% | 5 | Jan 26, 2026 | |
| DCTH Delcath Systems | Reiterates: Buy | $30 | $9.08 | +230.40% | 16 | Jan 9, 2026 | |
| CGEN Compugen | Initiates: Buy | $4 | $2.08 | +92.31% | 1 | Jan 7, 2026 | |
| EKSO Ekso Bionics Holdings | Downgrades: Neutral | n/a | $11.38 | - | 17 | Dec 31, 2025 | |
| PYXS Pyxis Oncology | Maintains: Buy | $5 → $7 | $1.37 | +410.95% | 11 | Dec 19, 2025 | |
| ABSI Absci | Maintains: Buy | $7 → $8 | $2.38 | +236.13% | 15 | Dec 18, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $70 → $45 | $13.84 | +225.14% | 14 | Dec 2, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $31 → $36 | $17.01 | +111.64% | 20 | Nov 21, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $20 | $2.86 | +599.30% | 4 | Nov 19, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $156 → $54 | $6.01 | +799.25% | 8 | Nov 18, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $130 → $155 | $99.41 | +55.92% | 5 | Nov 17, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Neutral | $77 → $94 | $115.00 | -18.26% | 11 | Nov 17, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $8.5 → $9 | $3.32 | +171.08% | 14 | Nov 14, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $55 → $32 | $15.12 | +111.64% | 16 | Nov 14, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $10 → $13 | $7.84 | +65.82% | 19 | Nov 11, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $40 → $47 | $65.20 | -27.91% | 8 | Nov 10, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $3.5 → $5 | $3.76 | +32.98% | 18 | Nov 10, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Assumes: Buy | $7,500 | $4.55 | +164,735.16% | 1 | Nov 4, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgrades: Buy | $5 | $1.63 | +206.34% | 18 | Oct 29, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $9 → $22 | $6.59 | +233.84% | 2 | Oct 29, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Assumes: Buy | $3 | $0.77 | +290.83% | 1 | Oct 23, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $16 | $3.18 | +403.14% | 14 | Oct 20, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $11 | $0.61 | +1,715.18% | 12 | Aug 21, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Neutral | $15 | $1.70 | +782.35% | 2 | Aug 14, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $4 → $3 | $1.11 | +170.27% | 2 | Aug 12, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $7 | $1.61 | +334.78% | 22 | Jun 24, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | n/a | $0.86 | - | 7 | May 19, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $3 | $0.79 | +279.65% | 3 | May 19, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $5 → $2 | $2.21 | -9.50% | 15 | May 9, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $3.5 | $1.40 | +150.00% | 4 | Apr 2, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $19 | $4.13 | +360.05% | 14 | Mar 28, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $240 → $180 | $1.72 | +10,365.12% | 15 | Mar 14, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $33 | $5.20 | +534.62% | 18 | Feb 26, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $125 | $7.95 | +1,472.33% | 2 | Nov 21, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $11 | $4.50 | +144.44% | 8 | May 1, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $20 | $0.73 | +2,651.03% | 1 | Apr 1, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $9 | $6.75 | +33.33% | 1 | Dec 8, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Neutral | n/a | $3.61 | - | 2 | Aug 16, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Neutral | n/a | $1.23 | - | 12 | May 9, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $150 → $25 | $1.21 | +1,966.12% | 2 | Jan 30, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $5 | $2.84 | +76.06% | 1 | Dec 7, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $90 → $120 | $2.77 | +4,232.13% | 1 | Nov 4, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $25 → $20 | $0.17 | +11,818.95% | 2 | Aug 10, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Neutral | n/a | $18.14 | - | 8 | May 13, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $9.5 → $6 | $15.80 | -62.01% | 4 | Jul 16, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $20 → $15 | $1.33 | +1,027.82% | 5 | Nov 9, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $30 → $33 | $6.38 | +417.24% | 1 | Mar 16, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $8 → $9.5 | $12.23 | -22.32% | 3 | Mar 6, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $18,000 → $14,000 | $0.92 | +1,521,639.13% | 1 | Mar 5, 2020 |
Eton Pharmaceuticals
Mar 2, 2026
Maintains: Buy
Price Target: $35 → $37
Current: $16.80
Upside: +120.24%
Vericel
Feb 27, 2026
Maintains: Buy
Price Target: $60 → $64
Current: $33.71
Upside: +89.85%
Corcept Therapeutics
Feb 25, 2026
Maintains: Buy
Price Target: $67 → $60
Current: $33.87
Upside: +77.15%
electroCore
Jan 26, 2026
Maintains: Buy
Price Target: $25 → $18
Current: $6.85
Upside: +162.77%
Mirum Pharmaceuticals
Jan 26, 2026
Maintains: Buy
Price Target: $102 → $130
Current: $86.30
Upside: +50.64%
Delcath Systems
Jan 9, 2026
Reiterates: Buy
Price Target: $30
Current: $9.08
Upside: +230.40%
Compugen
Jan 7, 2026
Initiates: Buy
Price Target: $4
Current: $2.08
Upside: +92.31%
Ekso Bionics Holdings
Dec 31, 2025
Downgrades: Neutral
Price Target: n/a
Current: $11.38
Upside: -
Pyxis Oncology
Dec 19, 2025
Maintains: Buy
Price Target: $5 → $7
Current: $1.37
Upside: +410.95%
Absci
Dec 18, 2025
Maintains: Buy
Price Target: $7 → $8
Current: $2.38
Upside: +236.13%
Dec 2, 2025
Maintains: Buy
Price Target: $70 → $45
Current: $13.84
Upside: +225.14%
Nov 21, 2025
Maintains: Buy
Price Target: $31 → $36
Current: $17.01
Upside: +111.64%
Nov 19, 2025
Reiterates: Buy
Price Target: $20
Current: $2.86
Upside: +599.30%
Nov 18, 2025
Maintains: Buy
Price Target: $156 → $54
Current: $6.01
Upside: +799.25%
Nov 17, 2025
Maintains: Buy
Price Target: $130 → $155
Current: $99.41
Upside: +55.92%
Nov 17, 2025
Downgrades: Neutral
Price Target: $77 → $94
Current: $115.00
Upside: -18.26%
Nov 14, 2025
Maintains: Buy
Price Target: $8.5 → $9
Current: $3.32
Upside: +171.08%
Nov 14, 2025
Maintains: Buy
Price Target: $55 → $32
Current: $15.12
Upside: +111.64%
Nov 11, 2025
Maintains: Buy
Price Target: $10 → $13
Current: $7.84
Upside: +65.82%
Nov 10, 2025
Maintains: Buy
Price Target: $40 → $47
Current: $65.20
Upside: -27.91%
Nov 10, 2025
Maintains: Buy
Price Target: $3.5 → $5
Current: $3.76
Upside: +32.98%
Nov 4, 2025
Assumes: Buy
Price Target: $7,500
Current: $4.55
Upside: +164,735.16%
Oct 29, 2025
Upgrades: Buy
Price Target: $5
Current: $1.63
Upside: +206.34%
Oct 29, 2025
Maintains: Buy
Price Target: $9 → $22
Current: $6.59
Upside: +233.84%
Oct 23, 2025
Assumes: Buy
Price Target: $3
Current: $0.77
Upside: +290.83%
Oct 20, 2025
Reiterates: Buy
Price Target: $16
Current: $3.18
Upside: +403.14%
Aug 21, 2025
Reiterates: Buy
Price Target: $11
Current: $0.61
Upside: +1,715.18%
Aug 14, 2025
Reiterates: Neutral
Price Target: $15
Current: $1.70
Upside: +782.35%
Aug 12, 2025
Maintains: Buy
Price Target: $4 → $3
Current: $1.11
Upside: +170.27%
Jun 24, 2025
Reiterates: Buy
Price Target: $7
Current: $1.61
Upside: +334.78%
May 19, 2025
Reiterates: Buy
Price Target: n/a
Current: $0.86
Upside: -
May 19, 2025
Reiterates: Buy
Price Target: $3
Current: $0.79
Upside: +279.65%
May 9, 2025
Maintains: Buy
Price Target: $5 → $2
Current: $2.21
Upside: -9.50%
Apr 2, 2025
Reiterates: Buy
Price Target: $3.5
Current: $1.40
Upside: +150.00%
Mar 28, 2025
Reiterates: Buy
Price Target: $19
Current: $4.13
Upside: +360.05%
Mar 14, 2025
Maintains: Buy
Price Target: $240 → $180
Current: $1.72
Upside: +10,365.12%
Feb 26, 2025
Reiterates: Buy
Price Target: $33
Current: $5.20
Upside: +534.62%
Nov 21, 2024
Reiterates: Buy
Price Target: $125
Current: $7.95
Upside: +1,472.33%
May 1, 2024
Reiterates: Buy
Price Target: $11
Current: $4.50
Upside: +144.44%
Apr 1, 2024
Reiterates: Buy
Price Target: $20
Current: $0.73
Upside: +2,651.03%
Dec 8, 2023
Initiates: Buy
Price Target: $9
Current: $6.75
Upside: +33.33%
Aug 16, 2023
Downgrades: Neutral
Price Target: n/a
Current: $3.61
Upside: -
May 9, 2023
Downgrades: Neutral
Price Target: n/a
Current: $1.23
Upside: -
Jan 30, 2023
Maintains: Buy
Price Target: $150 → $25
Current: $1.21
Upside: +1,966.12%
Dec 7, 2022
Initiates: Buy
Price Target: $5
Current: $2.84
Upside: +76.06%
Nov 4, 2022
Maintains: Buy
Price Target: $90 → $120
Current: $2.77
Upside: +4,232.13%
Aug 10, 2022
Maintains: Buy
Price Target: $25 → $20
Current: $0.17
Upside: +11,818.95%
May 13, 2022
Downgrades: Neutral
Price Target: n/a
Current: $18.14
Upside: -
Jul 16, 2021
Maintains: Buy
Price Target: $9.5 → $6
Current: $15.80
Upside: -62.01%
Nov 9, 2020
Maintains: Buy
Price Target: $20 → $15
Current: $1.33
Upside: +1,027.82%
Mar 16, 2020
Maintains: Buy
Price Target: $30 → $33
Current: $6.38
Upside: +417.24%
Mar 6, 2020
Reiterates: Buy
Price Target: $8 → $9.5
Current: $12.23
Upside: -22.32%
Mar 5, 2020
Reiterates: Buy
Price Target: $18,000 → $14,000
Current: $0.92
Upside: +1,521,639.13%